How Innovation Can Address Global Threats to Access Posed by Climate Crisis
On World Contraception Day, let’s consider the international implications of the climate crisis on medications and medical devices.
top of page
News
Exchanges
Dec 15, 20221 min read
CTI Exchange Youth Engagement at ICFP
Below is the poster that was presented by members of the CTI Exchange Youth Council at this year's International Conference on Family...
44 views
Exchanges
Oct 14, 20221 min read
Recent Contraceptive Research and Development Funding Announcements
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a number of recent funding opportunity...
96 views
Exchanges
Jun 1, 20223 min read
Official Video Release: We Don’t Have Bad Blood!
Contraceptive-induced menstrual changes (CIMCs) contribute to both non-use and discontinuation of contraception. Reduced bleeding and...
213 views
Exchanges
Jan 11, 20221 min read
Updated Couple Years of Protection: Literature Review and Guidance
Read more about the updated CYP on the FHI 360 website and USAID's website. Couple year protection (CYP) is an output indicator that was...
192 views
Exchanges
Jun 10, 20211 min read
New report brings human rights perspectives to LARC service provision in the UK
Post written by Margaret Gaw, Stanback Fellow with FHI 360 A new report by the British Pregnancy Advisory Service (BPAS), researchers at...
46 views
Exchanges
Jun 1, 20211 min read
New report examines the strengths and weaknesses of SRH supply chains during COVID-19
The COVID-19 pandemic has created acute disruptions to public health supply chains, revealing underlying vulnerabilities in the global...
67 views
Exchanges
May 10, 20211 min read
Highlighting the drospirenone progestin-only pill
The drospirenone progestin-only pill (POP) is an estrogen-free daily oral contraceptive that received regulatory approval in both the US...
68 views
Exchanges
Sep 16, 20201 min read
Mirena levonorgestrel-releasing intrauterine system now approved for 6 years of pregnancy prevention
The United States Food and Drug Administration (FDA) approved Mirena® for an additional year of duration, extending its indication for up...
235 views
Exchanges
Aug 17, 20201 min read
Special issue of Biology of Reproduction highlights contraceptive development
Sparked by conversations from the 2019 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)...
85 views
Exchanges
May 22, 20201 min read
The FDA Approves the First Non-Hormonal Prescription Birth Control Gel, Phexxi™
The U.S. Food and Drug Administration has issued approval for a new type of birth control gel.
199 views
Exchanges
Feb 26, 20201 min read
Trials Methodology Research Partnership Grant – now OPEN!
The Global Health Network has announced that the Trials Methodology Research Partnership (TMRP) has made available funds for small...
38 views
Exchanges
Jan 28, 20202 min read
Predicting Menopause: There Just May be a Test for That
A woman’s menstrual cycle – though critical for conceiving life, can also be painful, messy, and downright uncomfortable. And, women who...
28 views
Exchanges
Jan 24, 20202 min read
Amphora Shows Promise in Clinical Trials
Amphora, an investigational Multipurpose Vaginal pH Regulator (MVP-RTM), shows promise for the United States Food and Drug Administration...
55 views
Exchanges
Dec 17, 20191 min read
U.S. Food and Drug Administration Approves First Generic Contraceptive Vaginal Ring
On December 11, 2019, Amneal Pharmaceuticals received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug...
59 views
Exchanges
Dec 12, 20192 min read
Microneedle Patch Delivers Long-Acting Reversible Contraception
Researchers from the Georgia Institute of Technology, University of Michigan and FHI 360, are attempting to expand the number of user...
54 views
Exchanges
Dec 5, 20192 min read
Is a once-a-month birth control pill on the horizon?
Researchers may have found a novel delivery mechanism that will allow an extended release birth control pill to provide one month of...
28 views
Exchanges
Dec 4, 20191 min read
Takeaways from the 2019 FDA Complex Generic Drug Product Development Workshop
In late September, the Federal Drug Administration (FDA) hosted its second annual Complex Generic Drug Product Development Workshop...
46 views
Exchanges
Nov 7, 20191 min read
LILETTA® levonorgestrel-releasing intrauterine system now FDA-approved for use for up to 6 years
Medicines360 and Allergan announced the U.S. Food and Drug Administration (FDA) approved the extension of LILETTA® (levonorgestrel...
44 views
Exchanges
Oct 22, 20191 min read
The Initiative for Multipurpose Prevention Technologies (IMPT) Ten-Year Retrospective Report
Imagine using one product or method to safeguard against an unwanted pregnancy or a sexually transmitted infection. Well, there’s a tech...
31 views
Exchanges
Oct 21, 20192 min read
Pressing Pause on Your Fertility: Contraception via Egg Hibernation
Novel research from David Pépin’s lab's research may serve women as both a contraceptive and a fertoprotective – protecting against the...
40 views
Exchanges
Oct 17, 20191 min read
The Demographic and Health Surveys (DHS) Program Updates Questionnaires
The Demographic and Health Surveys (DHS) Program has updated its questionnaires for DHS-8. Since 1984, the DHS Program has provided...
12 views
Exchanges
Sep 23, 20191 min read
NICHD Releases Five-Year Strategic Plan
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has publicly released its updated five-year...
24 views
Exchanges
Jul 15, 20191 min read
Rebuilding Incentives for Research and Development of Medicines
On July 11, 2019, the U.N. Human Rights Council (HRC) adopted a new resolution on “Access to medicines and vaccines in the context of the...
9 views
Exchanges
Jun 14, 20192 min read
ECHO Trial Results Show that Three Methods Do Not Increase Risk of HIV
The ECHO trial, a randomized controlled trial, found no meaningful difference in risk of HIV acquisition across three contraceptive...
32 views
Exchanges
Jun 5, 20191 min read
Planning for Outcomes Tool Helps Estimate Impact of Changing Contraceptive Method Mix
In response to observational studies that suggest a link between DMPA and risk fo HIV acquisition, FHI 360 has developed a modeling tool...
15 views
Exchanges
Apr 25, 20191 min read
One contraceptive for both men and women
YourChoice Therapeutics is attempting to revolutionize birth control options for women & men by developing options that are hormone-free...
17 views
Exchanges
Apr 16, 20191 min read
Ovaprene® holds promise as non-hormonal contraceptive
Ovaprene®, a non-hormonal, monthly birth control ring for women, has been identified as a first-in-category contraceptive product to...
365 views
Exchanges
Apr 11, 20191 min read
Potential role of genetics in contraceptive failure
A small percentage of women may become pregnant even with “perfect” use of contraceptives. Researchers have turned to pharmacogenetics to...
10 views
Exchanges
Apr 1, 20192 min read
Contraceptive Jewelry Under Development
In the future, preventing pregnancy may be as easy as putting on jewelry. According to an article in the Journal of Controlled Release...
16 views
Exchanges
Mar 13, 20191 min read
It’s an exciting time at the CTI Exchange!
Since 2015, the CTI Exchange has served as a platform to increase global access to information and resources that supports contraceptive ...
5 views
Exchanges
Feb 5, 20191 min read
DHS Program Seeks Feedback on Model Questionnaires
The Demographic and Health Surveys (DHS) Program is currently soliciting feedback on its model questionnaires, optional modules, and bio...
7 views
Exchanges
Jan 30, 20191 min read
NICHD Solicits Feedback on Strategic Plan
The NICHD has issued a Request for Information (RFI) to solicit feedback on its new strategic plan. NICHD is seeking input from a variety...
8 views
Exchanges
Jan 17, 20191 min read
Microneedle patches designed to deliver long-acting contraceptive hormone
Sustained hormonal release of a contraceptive hormone may be possible via the use of biodegradable levonorgestrel-releasing microneedle...
15 views
Exchanges
Jan 17, 20191 min read
FDA plans new office to revamp drug review process
The United States Food and Drug Administration (U.S.FDA) has plans to create the Office of Drug Evaluation Science (ODES) in an effort to...
6 views
Exchanges
Dec 7, 20181 min read
International Conference on Family Planning
From November 12-15, more than 3,700 people gathered for the fifth International Conference on Family Planning (ICFP) in Kigali, Rwanda....
22 views
Exchanges
Dec 7, 20181 min read
Launch of first clinical trial for male contraceptive gel
In November 2018, the Population Council, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the..
9 views
Exchanges
Sep 25, 20181 min read
Celebrating #NextGenContraception on World Contraception Day
The CTI Exchange joins global partners in celebrating World Contraception Day which takes place on September 26th each year. To celebrate...
11 views
Exchanges
Aug 13, 20181 min read
FDA approvals for Annovera and Natural Cycles app
On August 10, 2018, the U.S. Food and Drug Administration made two major announcements related to contraception. First, it permitted ...
18 views
Exchanges
Jul 31, 20181 min read
New Summer Twitter Campaign: #NextGenContraception
The Contraceptive Technology Innovation Exchange’s summer social media campaign aims to highlight the importance of new contraceptive...
7 views
Exchanges
Jul 30, 20181 min read
Report on the International Family Planning Landscape
The Center for Global Development (CGD) and Kaiser Family Foundation (KFF) held an international family planning leadership retreat from...
3 views
Exchanges
Jul 18, 20181 min read
Newly Published Results of a Phase I/II Trial for LNG-only Patches
A recently published article reports on a phase I/II pharmacokinetic and pharmacodynamic clinical trial of two levonorgestrel (LNG)-only ...
4 views
Exchanges
Jul 5, 20181 min read
Published Review on Responses to Contraceptive-Induced Menstrual Changes
A recently published article in Reproductive Health summarizes research on women’s responses to contraceptive-induced menstrual bleeding...
9 views
Exchanges
Jul 2, 20181 min read
Vaginal Ring Dose-Finding Results Published
Contraceptive vaginal rings (CVRs) offer women a self-controlled, non-daily delivery system. One CVR – the FDA approved NuvaRing® – is on...
7 views
Exchanges
May 8, 20181 min read
Sperm Motility Inhibited in Study of Male Macaques
Male contraceptive targets under development focus on sperm production or sperm delivery (blockage or loss of function). One protein of...
5 views
Exchanges
Mar 13, 20181 min read
Daré Bioscience & Orbis Biosciences to Collaborate on Injectables
Daré Bioscience and Orbis Biosciences have agreed to collaborate on development of two etonogestrel-based injectable contraceptives. The...
7 views
Exchanges
Feb 15, 20181 min read
Family Planning Global Handbook Updated
The 2018 edition of “Family Planning: A Global Handbook for Providers” is now available. The handbook provides up-to-date family planning...
10 views
Exchanges
Feb 14, 20181 min read
Contraceptive Implant Strategic Partnership Announced
DKT International and Shanghai Dahua Pharmaceutical have entered into a strategic partnership to expand the availability, accessibility...
48 views
Exchanges
Jan 8, 20181 min read
FDA Proposes Female Condom Rule Change
The U.S. Food and Drug Administration has released a proposed order to reclassify & rename the single-use female condom. Reclassification...
22 views
Exchanges
Jan 4, 20181 min read
FDA to Review One-year Vaginal Ring
The U.S. Food and Drug Administration (FDA) has accepted for review a contraceptive vaginal ring developed by the Population Council...
18 views
bottom of page